Published in J Virol on April 02, 2008
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS (2009) 2.53
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol (2009) 2.47
Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res (2008) 2.40
Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med (2013) 2.29
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology (2009) 2.02
Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol (2015) 1.80
Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One (2008) 1.75
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology (2010) 1.51
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology (2011) 1.42
Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol (2012) 1.36
Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem (2010) 1.15
Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput Biol (2010) 1.15
Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells. J Virol (2008) 1.06
Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition. J Infect Dis (2009) 1.00
Eradication therapies for HIV Infection: time to begin again. AIDS Res Hum Retroviruses (2011) 0.99
Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology (2011) 0.99
HIV and T follicular helper cells: a dangerous relationship. J Clin Invest (2012) 0.96
Achieving a cure for HIV infection: do we have reasons to be optimistic? J Antimicrob Chemother (2012) 0.95
The evolution of HIV: inferences using phylogenetics. Mol Phylogenet Evol (2011) 0.94
HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells. Scientifica (Cairo) (2013) 0.93
Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies. J Virol (2009) 0.91
HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites. AIDS Res Ther (2010) 0.90
HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination. J Immunol (2011) 0.89
HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression. PLoS One (2013) 0.89
Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire. J Virol (2010) 0.88
Role of p53 in neurodegenerative diseases. Neurodegener Dis (2011) 0.86
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection. Retrovirology (2011) 0.85
Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes. PLoS Pathog (2015) 0.84
Quantification of viral infection dynamics in animal experiments. Front Microbiol (2013) 0.84
Contribution of follicular dendritic cells to persistent HIV viremia. J Virol (2013) 0.83
TFH in HIV Latency and as Sources of Replication-Competent Virus. Trends Microbiol (2016) 0.82
Acute SIV infection in sooty mangabey monkeys is characterized by rapid virus clearance from lymph nodes and absence of productive infection in germinal centers. PLoS One (2013) 0.78
Nanotechnology Applications to HIV Vaccines and Microbicides. J Glob Infect Dis (2012) 0.78
Modeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimes. PLoS One (2012) 0.77
Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5. Virology (2015) 0.77
Impaired B cells survival upon production of inflammatory cytokines by HIV-1 exposed follicular dendritic cells. Retrovirology (2016) 0.76
Animal models to achieve an HIV cure. Curr Opin HIV AIDS (2016) 0.75
Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes. BMC Microbiol (2016) 0.75
Viruses exploit the tissue physiology of the host to spread in vivo. Curr Opin Cell Biol (2016) 0.75
Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary. Front Immunol (2017) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics (2003) 130.85
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
MODELTEST: testing the model of DNA substitution. Bioinformatics (1998) 101.19
Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol (1981) 67.56
TCS: a computer program to estimate gene genealogies. Mol Ecol (2000) 27.89
Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol (2004) 22.36
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science (1997) 15.12
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A (1997) 13.47
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68
LAMARC 2.0: maximum likelihood and Bayesian estimation of population parameters. Bioinformatics (2006) 6.49
Recombination in HIV-1. Nature (1995) 5.72
Consequences of recombination on traditional phylogenetic analysis. Genetics (2000) 5.01
The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med (2002) 4.73
Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72
Potential applications and pitfalls of Bayesian inference of phylogeny. Syst Biol (2002) 4.66
Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol (1999) 4.66
Intraspecific gene genealogies: trees grafting into networks. Trends Ecol Evol (2001) 4.61
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol (2000) 4.46
Recombination in AIDS viruses. J Mol Evol (1995) 3.94
The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev (1980) 3.53
Follicular dendritic cells and human immunodeficiency virus infectivity. Nature (1995) 3.22
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis (1991) 3.16
The effect of recombination on the accuracy of phylogeny estimation. J Mol Evol (2002) 3.11
Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A (1999) 3.00
The follicular dendritic cell: long term antigen retention during immunity. Immunol Rev (1980) 2.77
Sex and recombination in retroviruses. Trends Genet (1991) 2.08
The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. Exp Mol Pathol (1968) 1.86
Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol Rev (1997) 1.78
Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J Virol (2003) 1.62
Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships. Annu Rev Immunol (1989) 1.60
Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol (2000) 1.58
Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice. Immunology (1979) 1.57
Persistence of infectious HIV on follicular dendritic cells. J Immunol (2001) 1.54
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat Med (1998) 1.50
Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1. HIV Clin Trials (2003) 1.44
Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses (1990) 1.36
Role of complement in HIV infection. Annu Rev Immunol (1997) 1.18
Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr Top Microbiol Immunol (1995) 1.16
Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunol Rev (1997) 1.16
Importance and detection of virus reservoirs and compartments of HIV infection. Curr Opin Microbiol (2003) 1.14
HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol (2003) 1.13
Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2. J Virol (2000) 1.11
Follicular dendritic cells and the persistence of HIV infectivity: the role of antibodies and Fcgamma receptors. J Immunol (2002) 1.03
Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood. J Virol (2001) 0.97
Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. AIDS Rev (2003) 0.97
Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles. J Pathol (1993) 0.95
Follicular dendritic cells in HIV-induced lymphadenopathy and AIDS. APMIS Suppl (1989) 0.91
Latency and reservoirs for HIV-1. AIDS (1999) 0.89
The majority of human immunodeficiency virus type 1 particles present within splenic germinal centres are produced locally. J Gen Virol (2005) 0.88
Lymphadenopathy in HIV (HTLV-III/LAV) infected subjects: the role of virus and follicular dendritic cells. Cancer Detect Prev (1988) 0.84
Reservoirs of HIV infection or carriage: monocytic, dendritic, follicular dendritic, and B cells. Ann N Y Acad Sci (1993) 0.83
Silent, but deadly--eliminating reservoirs of latent HIV. Trends Biotechnol (2003) 0.82
Follicular dendritic cells and the maintenance of IgE responses. Eur J Immunol (1995) 0.79
HIV-1 dynamics at different time scales under antiretroviral therapy. J Theor Biol (2005) 0.78
Is HIV found in the cytoplasm of dendritic cells? Am J Pathol (1997) 0.77
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature (2005) 11.12
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol (2008) 6.91
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med (2008) 5.81
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med (2006) 5.36
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
Glycerol monolaurate prevents mucosal SIV transmission. Nature (2009) 5.02
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med (2009) 4.97
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
The causes and consequences of HIV evolution. Nat Rev Genet (2004) 4.34
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med (2007) 3.75
Many species in one: DNA barcoding overestimates the number of species when nuclear mitochondrial pseudogenes are coamplified. Proc Natl Acad Sci U S A (2008) 3.56
Immune clearance of highly pathogenic SIV infection. Nature (2013) 3.15
The effect of recombination on the accuracy of phylogeny estimation. J Mol Evol (2002) 3.11
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
The impact of species concept on biodiversity studies. Q Rev Biol (2004) 2.91
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature (2009) 2.78
Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest (2011) 2.55
Recombination in evolutionary genomics. Annu Rev Genet (2002) 2.54
Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med (2009) 2.41
Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology (2012) 2.30
Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med (2013) 2.29
Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol (2006) 2.27
A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis (2005) 2.25
Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol (2009) 2.14
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog (2010) 1.99
Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis (2008) 1.94
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
TreeSAAP: selection on amino acid properties using phylogenetic trees. Bioinformatics (2003) 1.91
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
Subterranean phylogeography of freshwater crayfishes shows extensive gene flow and surprisingly large population sizes. Mol Ecol (2005) 1.90
Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One (2010) 1.88
Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol (2004) 1.87
Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection. J Infect Dis (2012) 1.80
Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther (2012) 1.79
A macaque model of HIV-1 infection. Proc Natl Acad Sci U S A (2009) 1.76
Population genetics of microbial pathogens estimated from multilocus sequence typing (MLST) data. Infect Genet Evol (2005) 1.72
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS (2002) 1.68
Circulating proviral HIV DNA and HIV-associated dementia. AIDS (2005) 1.68
HIV-associated sensory neuropathies. AIDS (2002) 1.65
Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr (2013) 1.64
Pathoscope: species identification and strain attribution with unassembled sequencing data. Genome Res (2013) 1.62
Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin Invest (2011) 1.62
Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood (2012) 1.62
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest (2008) 1.57
Clinical validation of the NeuroScreen. J Neurovirol (2005) 1.57
HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS (2010) 1.56
Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read (2002) 1.56
Incorporating gaps as phylogenetic characters across eight DNA regions: ramifications for North American Psoraleeae (Leguminosae). Mol Phylogenet Evol (2007) 1.54
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A (2010) 1.52
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology (2004) 1.49
Role of microtubules in extracellular release of poliovirus. J Virol (2009) 1.49
Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy. AIDS Read (2005) 1.46
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43
Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J Immunol (2010) 1.42
A comparison of phylogenetic network methods using computer simulation. PLoS One (2008) 1.40
Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One (2011) 1.40
Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol (2003) 1.39
Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology (2005) 1.39
Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am J Pathol (2002) 1.38
Evolutionary biology in biodiversity science, conservation, and policy: a call to action. Evolution (2010) 1.36
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest (2013) 1.35
Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol (2006) 1.33
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr (2005) 1.32
Unraveling the evolutionary radiation of the thoracican barnacles using molecular and morphological evidence: a comparison of several divergence time estimation approaches. Syst Biol (2004) 1.28
Lost branches on the tree of life. PLoS Biol (2013) 1.26
Follicular dendritic cell regulation of CXCR4-mediated germinal center CD4 T cell migration. J Immunol (2004) 1.25
Comparing phylogenetic codivergence between polyomaviruses and their hosts. J Virol (2006) 1.25
Pathogen typing in the genomics era: MLST and the future of molecular epidemiology. Infect Genet Evol (2013) 1.24
Insights into the role of immune activation in HIV neuropathogenesis. J Neurovirol (2002) 1.24
Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol (2005) 1.23
Model-based multi-locus estimation of decapod phylogeny and divergence times. Mol Phylogenet Evol (2005) 1.23
Recombination estimation under complex evolutionary models with the coalescent composite-likelihood method. Mol Biol Evol (2006) 1.23
HIV-associated opportunistic infections of the CNS. Lancet Neurol (2012) 1.22
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine (2009) 1.22
Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain (2007) 1.21
Sleep, function and HIV: a multi-method assessment. AIDS Behav (2013) 1.20
A comprehensive and integrative reconstruction of evolutionary history for Anomura (Crustacea: Decapoda). BMC Evol Biol (2013) 1.20
Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol (2010) 1.19
Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol (2007) 1.15
Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J Mol Diagn (2006) 1.14
Barriers to mucosal transmission of immunodeficiency viruses. Blood (2011) 1.14
Molecular characterization of crustacean visual pigments and the evolution of pancrustacean opsins. Mol Biol Evol (2006) 1.14
In vitro modeling of the HIV-macrophage reservoir. J Leukoc Biol (2006) 1.13
Follicular dendritic cell contributions to HIV pathogenesis. Semin Immunol (2002) 1.12
Saving the clinician-scientist: report of the ANA long range planning committee. Ann Neurol (2006) 1.12